EW Short Volume
Edwards Lifesciences Corporation (EW) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $46.86B, listed on NYSE, employing roughly 15,800 people, carrying a beta of 0.87 to the broader market. Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. Led by Bernard J. Zovighian, public since 2000-03-27.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-05-15
- Short Volume
- 848.1K
- Total Volume
- 1.4M
- Short %
- 58.73%
- 30-Day Avg Short %
- 42.98%
Showing 30 days of FINRA short volume data for Edwards Lifesciences Corporation.
Learn how short volume is reported and how to read the data →
Frequently asked EW short volume questions
- What is the daily EW short volume?
- As of May 15, 2026, Edwards Lifesciences Corporation (EW) short volume is 848.1K shares against 1.4M total reported volume, or 58.73% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is EW short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does EW short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.